SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in Israel

TEL AVIV, Israel, Dec. 07, 2023 -- SciSparc Ltd. , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central...

Related Keywords

Israel ,Israeli , ,Company Or Scisparc ,Exchange Commission ,Scisparc Ltd ,Company The Acquisition ,Nasdaq ,Israel The Target Company ,Target Company ,Combined Company ,Tourette Syndrome ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,